2023
Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review
Ellingson M, Sheikha H, Nyhan K, Oliveira C, Niccolai L. Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review. Human Vaccines & Immunotherapeutics 2023, 19: 2239085. PMID: 37529935, PMCID: PMC10399474, DOI: 10.1080/21645515.2023.2239085.Peer-Reviewed Original ResearchConceptsVaccine effectivenessSystematic reviewHuman Papillomavirus Vaccine EffectivenessVaccine-type HPV infectionYounger ageHigh vaccine effectivenessHuman papillomavirus vaccineVaccine effectiveness studiesYounger age groupsAdolescents ages 15Adolescents ages 9HPV infectionHPV vaccineVaccine initiationPapillomavirus vaccineTime vaccinationAnogenital wartsCervical abnormalitiesCervical cancerDisease outcomeAge groupsOlder ageEffectiveness studiesAge 15Age
2019
Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis
Avni-Singer LR, Yakely A, Sheth SS, Shapiro ED, Niccolai LM, Oliveira CR. Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis. Public Health 2019, 178: 137-150. PMID: 31698136, PMCID: PMC6994345, DOI: 10.1016/j.puhe.2019.08.010.Peer-Reviewed Original ResearchConceptsHPV vaccineVaccine impact studiesSociodemographic disparitiesSystematic reviewImportant public health priorityHPV vaccine eraReduction of HPVPopulation-level burdenPublic health priorityPubMed/MEDLINEScience Citation IndexHPV infectionGenital wartsSocio-economic subgroupsCervical dysplasiaRoutine vaccinationVaccine eraVaccine impactCitation IndexHuman papillomavirusVaccine introductionSentinel surveillanceStudy protocolEligible studiesHealth priority